# Environmental Pollutants and Metabolic Disorders: The Multi-Exposure Scenario of Life

Brigitte Le Magueresse-Battistoni, Hubert Vidal, Danielle Naville

► To cite this version:

Brigitte Le Magueresse-Battistoni, Hubert Vidal, Danielle Naville. Environmental Pollutants and Metabolic Disorders: The Multi-Exposure Scenario of Life. Frontiers in Endocrinology, 2018, 9, pp.582. 10.3389/fendo.2018.00582. hal-01885597

HAL Id: hal-01885597

https://hal.science/hal-01885597

Submitted on 2 Oct 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
1 Environmental pollutants and metabolic disorders: the multi-exposure scenario of life

2

3

4 Le Magueresse-Battistoni Brigitte, Vidal Hubert, Naville Danielle

5

6

7

8 Affiliations:

9 Univ Lyon, CarMeN laboratory, INSERM U1060, INRA U1397, INSA Lyon, Université

10 Claude Bernard Lyon1, 69600 Oullins, France

11

12

13 Corresponding author:

14 Dr. B. Le Magueresse-Battistoni, PhD

15 CarMeN laboratory, INSERM U1060, Faculté de Médecine Lyon-Sud, Chemin du Grand

16 Revoyet, 69600 Oullins, France

17 Phone 33 (0)426235919, Fax 33 (0)426235916

18 E-mail: [brigitte.lemagueresse@inserm.fr](mailto:brigitte.lemagueresse@inserm.fr)

19

20

21 Running Title: the cocktail effect of chemicals

22 Key words: cocktail effect; mixture; endocrine disrupting compounds, EDCs; pollutants; sex-

23 dimorphism

24

25
26 Abstract

Obesity and diabetes have reached epidemic proportions the past few decades and continue to progress worldwide with no clear sign of decline of the epidemic. Obesity is of high concern because it is the main risk factor for a number of non-communicable diseases such as cardiovascular diseases and type 2 diabetes. Metabolic diseases constitute a major challenge as they are associated with an overall reduced quality of life and impose a heavy economic burden on countries. These are multifactorial diseases and it is now recognized that environmental exposure to man-made chemical pollutants is part of the equation. Yet, risk assessment procedures are based on a one-by-one chemical evaluation which does not meet the specificities of the multi-exposure scenario of life, e.g. a combined and long-term exposure to even the smallest amounts of chemicals. Indeed, it is assumed that environmental exposure to chemicals will be negligible based on the low potency of each chemical and that they do not interact. Within this mini-review, strong evidences are brought that exposure to low levels of multiple chemicals especially those shown to interfere with hormonal action, the so-called endocrine disrupting compounds do trigger metabolic disturbances in conditions in which no effect was expected if considering the concentration of each individual chemical in the mixture. This is known as the cocktail effect. It means that risk assessment procedures are not protective enough and thus that it should be revisited for the sake of Public Health.

44

45
46

**Introduction**

Obesity and diabetes have reached epidemic proportions the past few decades and continue to progress worldwide with no clear sign of decline of the epidemic in any country. An estimate of 1.9 billion adults were overweight in 2016 of these over 650 million were obese. Children and teenagers are also of high concern with 380 million overweight or obese in 2016. Latest projections by WHO (World Health Organization) indicate that proportion of overweight and obese males and females will continue to increase and reach 3.3 billion by 2030 [1]. Obesity is of high concern because it is the main risk factor for a number of non-communicable diseases such as cardiovascular diseases, certain cancers and type 2 diabetes. Indeed, almost 90% of persons suffering from type 2 diabetes are obese and more than 400 million persons will suffer from diabetes by 2030. Metabolic diseases constitute a major challenge as they are associated with an overall reduced quality of life, psychological problems and several physical disabilities [1; 2]. Metabolic diseases also impose a heavy economic burden on countries. It is a major cause of death and it costs an average of $ 2000 billion to the global economy, almost 3 points of GDP (gross domestic product) [3; 4].

Metabolic diseases are multifactorial diseases. Apart from genetic susceptibility, life-style risk factors associating over-nutrition and sedentary behavior are major contributors. Yet these causative factors do not explain the magnitude of metabolic diseases or the kinetics of the epidemic. Among other etiologic factors, it is acknowledged that environmental exposure to man-made chemical pollutants is part of the equation, especially those shown to interfere with hormonal action, the so-called endocrine disrupting compounds (EDCs) [5; 6; 7; 8; 9; 10; 11; 12].

Today's non-occupational exposure to chemicals is characterized by exposure to tens of thousands of man-made chemicals at low levels. Occupational exposure will not be considered in this mini-review. Another characteristic of non-occupational exposure is its chronicity, from conception onwards thus encompassing gestation and lactation which are periods highly vulnerable to chemicals. It is indeed recognized that threat during the maternal period (e.g. food restriction, chemical stressors) could trigger diseases later in life including metabolic diseases and some cancers, known as the Developmental Origin of Human adult Diseases (DOHaD) concept [13; 14]. In addition, the nature of chemicals and doses to which individuals are exposed may vary across their lifespan. It is also of concern that the number of chemicals to which humans are exposed has continued to grow for more than hundred years
as is their spatial distribution while the identification of their possible hazardous effects lags
behind. Furthermore, exposure is non-deliberate and the exposed population is seldom aware
of the nature of the chemicals, the levels to which it is exposed as well as the health
consequences. Hence, it appears that risk assessment procedures need to be revisited because
the one-by-one evaluation of chemicals does not meet the specificities of the multi-exposure
scenario of life.

Within this mini-review we aim in presenting basic characteristics on environmental
pollutants including EDCs and risk assessment principles operating nowadays. We will next
summarize evidences gathered using either natural or artificial mixtures in experimental
models, that exposures to low levels of multiple chemicals trigger metabolic disorders in
conditions in which no effect was expected if considering the concentration of each individual
chemical in the mixture. This is defined as the cocktail effect of pollutants which certainly
constitutes one of the biggest health challenges in our modern societies.

91

92 Risk Assessment Evaluation Principles and Limits

93
If industrialization has promoted societal progress improving life expectancy, it also led to the
presence of tens of thousands of anthropogenic chemicals transported in the atmosphere and
95
globalizing pollution. Man-made sources of pollution are related to industrial and agricultural
activities but also to domestic activities. Pollutants are found in foods, beverages and
97
packaging, clothes, cosmetics and cleaning products, furniture, paints, electronic equipment,
plastics and the list is long. Routes of exposure are mostly through diet but also dermal and by
99
inhalation not to mention transfer via placenta, suckling and mouthing behavior placing
babies and small infants at particularly high risk for they lack a mature defensive xenobiotic
100
detoxification system. Pollutants differ according to their natural disposal in degradable and
101
low-degradable or persistent pollutants including the lipophilic persistent organic pollutants
103
(POPs) which bio-accumulate through the food chain in fatty tissues with half-lives of several
104
years in humans [15]. Although severely regulated because of environmental toxicity (e.g.,
105
the ban of polychlorobiphenyls, PCBs, in the 1970's), POPs still contaminate air, soil and
106
water compartments. Other pollutants may be more quickly degradable, particularly those
produced by the plastic industry (phthalates and bisphenols) but because they are produced at
107
very high volumes and massively found in daily consumables they are consistently detected in
108
human body fluids such as plasma or urine, thus reflecting substantial and continuous
109
exposure [16; 17]. However regulatory bodies, e.g., the U.S. Environmental Protection agency (EPA) or the European Food Safety Agency (EFSA), do not consider combined exposures in risk assessment procedures or long-term exposure to even the smallest amount of chemicals. Exposure limits are setup for each individual chemical with the definition of reference doses such as the Tolerable Daily Intake (TDI). TDIs are extrapolated from the no or low observed adverse effect level (NoAEL/LoAEL) in experimental studies assuming linearity of the effects and therefore a threshold under which effects will be negligible. With this assumption (which does not apply to genotoxicant carcinogens for which there is no threshold), it can be deduced that risks arising from environmental exposure to chemicals in a real life exposure scenario will be negligible based on the low potency of each chemical of the mixture. But this assumption excludes several aspects linked to environmental exposure and related to the concept of threshold and the supposed linearity of the adverse effects not to mention the effects at low doses. By low doses it is meant environmental doses or concentrations found in biological fluids or doses approaching toxicological reference values [18]. This indicates that risk assessment procedures may not be protective enough when it comes to environmental exposure to chemicals and more specifically to EDCs.

126

## EDCs and some of their characteristics

EDCs are exogenous substances or mixture of chemicals that interfere with any aspect of hormone action, i.e. EDCs can mimic or antagonize hormonal action and interfere with the mechanism of hormonal production, transport or metabolism [12]. Energy homeostasis is one of the multiple physiological functions controlled by the endocrine system and as such a target of EDCs. It depends on the integrated action of various hormones including insulin, leptin, growth hormone, thyroid hormones, glucocorticoids but also sex hormones. Importantly, the hormonal interplay intricacies and the nature of the hormones at stake vary with age and sex and the state of maturity of the endocrine function of concern. For example, regulation of metabolism is highly age- and sex- dependent e.g. feeding behavior, distribution of fat masses and insulin sensitivity [19]. Thus, considering the intrinsic properties of the endocrine system and the definition of the EDCs based on their mode of action and not their chemical structure, the important parameters that should be considered in risk assessment evaluation are: 1) the dose and the non-linearity of the induced effects, 2) the timing and the length of exposure and 3) the simultaneous presence of several chemicals in mixture [18; 20; 21]. Additionally, it is emphasized that the less an endocrine function is mature at the time of chemical exposure, the more dramatic health adverse effects will happen defining highly
144

vulnerable periods such as gestation and lactation. For example, ancestral exposure of mice to obesogen chemicals such as organotin tributyltin (TBT) was found to predispose unexposed descendants to obesity [22].

145

146

147

About a thousand of chemicals could display EDC activities [23] and a subset was identified as metabolic disruptors because they favor/aggravate obesity and/or insulin resistance leading to diabetes. Metabolic disruptors may include Bisphenol A (BPA) and dichlorodiphenyltrichloroethane (DDT) but also certain pesticides, perfluorinated compounds and phthalates in addition to TBT which can target the signalling pathways of different nuclear receptors including the steroid receptors, but also xenobiotic receptors or receptors activated by peroxisome proliferators, PPAR (peroxisome proliferator-activated receptor) and its heterodimeric partner retinoid X receptor (RXR), not to mention non-genomic signalling pathways and cross-talk with the various nuclear receptors [24; 25; 26; 27].

148

149

150

151

152

153

154

155

156

157

## Evidences for a cocktail effect from natural or artificial mixtures on metabolic disruption and its sex-dimorphism

158

159

First evidences of a cocktail effect resulting from exposure to environmental mixtures were brought by scientists invested in Biology of Reproduction with the demonstration of additive effects in mixtures containing chemicals sharing a similar mechanism of action and combined in mixtures at concentrations that individually do not result in observable adverse effects. This was called the something from “nothing” phenomenon demonstrated originally with a mixture of 8 weak estrogenic chemicals [28] but also using combinations of anti-androgens [29] or more complex mixtures of anti-androgenic pesticides, antioxidants, industrial pollutants and chemicals present in personal care products [30]. The concept of additivity was also the basis of the Toxic Equivalent Factor (TEF) set up by the WHO [31] to facilitate risk assessment of “natural” mixtures of dioxins, furans and dioxin-like PCBs, using the dioxin of Seveso (named after the industrial explosion in the village of Seveso, Italy), the most potent in activating the aryl hydrocarbon receptor (AhR), as reference.

160

161

162

163

164

165

166

167

168

169

170

171

First demonstrations of mixture effects in the metabolic disruption field area emerged less than 10 years ago (Table 1) when it was observed that rats fed refined salmon oil for 28 days exhibited better metabolic outcomes than rats fed crude salmon oil [32]. These experiments suggested that exposure to POPs commonly present in food chains could trigger enhanced body weight and visceral fat, liver steatosis, glucose intolerance and insulin resistance [32] as well as chronic low-grade inflammation in adipose tissue [33]. A few years later, we brought

172

173

174

175

176
[34] the proof-of-concept study that a mixture of low-dosed pollutants not sharing similar mechanisms of action, could trigger metabolic disturbances in mice. Our original model was designed to take into consideration several parameters of the real life including chronic exposure at low doses covering all developmental stages from the fetal period to adult onwards. It even started when dams were immature females of 5 weeks of age. Both male and female mice (and not only adult males as classically studied) were evaluated to explore the sex-biased mechanisms linked to endocrine disruption. The pollutant cocktail was incorporated in either a high-fat high-sucrose (HFHS) diet [34] or a standard diet [35] to reflect different nutritional situations also considering that food is a primary route of exposure. Thus, we selected pollutants known to contaminate food and not sharing similar mechanisms of action to better reflect a “real” scenario of exposure. The mixture was made of two persistent pollutants including the most powerful dioxin (2,3,7,8-Tetrachlorodibenzo-p-dioxin, TCDD) and the most abundant of the non-dioxin like PCBs (PCB153). The other two were short-lived pollutants including BPA, one of the substances most investigated for its endocrine disrupting activities [18; 36; 37] and the di-[2-ethylhexyl] phthalate (DEHP) largely used to soften plastics. Each chemical in the mixture was used at a dose in the range of its tolerable daily intake (TDI). With regards to their modes of action, these well-recognized EDCs display mostly estrogeno-mimetic and anti-androgenic activities for BPA and DEHP, respectively; while dioxins interact with AhR and non-dioxin like PCBs may interact with other xenobiotic receptors such as constitutive androstane receptor (CAR) and pregnane X receptor (PXR) [18; 24; 38; 39]. Moreover, interaction of pollutants of the mixture may also occur with other receptors like thyroid receptors or glucocorticoid receptors not to mention extensive cross-talks which may occur via direct or indirect interaction with metabolic pathways regulating energy homeostasis as reviewed elsewhere [8; 24]. With such a model, we originally demonstrated that the metabolic adverse impact in mice exposed to the mixture lifelong occurs in the absence of any weight gain but was strongly sex-dependent [34; 40], and also related to the age of the animals [41] and their nutritional environment [35]. The female offspring exposed to the mixture incorporated in a HFHS diet exhibited aggravated glucose intolerance, impaired estrogen signalling in liver and enhanced expression of inflammatory markers in the adipose tissue at adulthood as compared to non-exposed females. This suggested that pollutants could lessen the protection of estrogens against the development of metabolic diseases. Importantly, these effects were not observed in younger females or in males which are characterized by different hormonal milieu in line with endocrine disrupting effects. Males had impaired cholesterol metabolism resulting from
enhancement of genes encoding proteins related to cholesterol synthesis and degradation in
bile salts when fed a HFHS diet containing the mixture of pollutants [34; 41]. The observed
metabolic impact in females was dependent on the nutritional context as female mice fed a
standard diet and exposed similarly to the mixture showed alteration of lipid homeostasis with
no difference in body weight or glucose tolerance [35]. Importantly, pollutants elicited
distinct and common features as compared to a HFHS diet as revealed by a comparative
hepatic transcriptomic study. Among features resulting from pollutant exposure in the liver
was the finding of several dysregulated genes belonging to the circadian clock metabolic
pathway including major canonical genes of the core clock (Period circadian regulators 1-3,
Arnt11 encoding BMAL1 and Clock) and clock regulators thus highlighting circadian
disruption [35]. None of the described effects observed in females were described in males
pointing to the sex-dimorphic impact of pollutants consistent with the sex-dimorphic
regulation of energy homeostasis [42] (Table 1).

Other combinations of low-dosed pollutants in mixture have later been tested in mouse [43;
44; 45] or rat [46] models as well as in juvenile seabream [47]. These studies also reported
significant alterations of the hepatic gene signature consistent with the liver being the primary
site for detoxification (Table 1). Interestingly, whenever males and females have been studied,
sex-differences have also been observed [43; 45; 46] as compiled (Table 1) which highlights
the necessity, as mandated by the National Institutes of Health (NIH), to consider sex as a
biological variable [48]. Also consistent with our data [34] [35], it was shown that the
nutritional component was as well a variable to consider. Indeed, exposure to a mixture of
POPs [44], to dioxins [49] or to a pharmaceutical drug cocktail [50] resulted in differential
metabolic responses between lean and obese mice. Outcomes surveyed included hepatic
steatosis and systemic lipid metabolism [44], hyperglycaemia and hepatic mitochondrial
function [50] and hepatic fibrosis [49]. Whether this is linked to substantial alterations of the
expression of hepatic xenobiotic processed genes [35; 51], resulting in differential ability of
the liver to detoxify chemicals, warrants further studies.

238

239 **Conclusions**

The current legislation on chemical risk assessment is definitely obsolete and needs to be
updated to take into account the cocktail effect of mixtures. This is certainly a major
challenge for the near future as environmental pollutants are risk factors for numerous
pathologies also including cancers and hormono-dependent cancers among them, for which
obesity is a risk factor [7]. Importantly, it was assumed that the carcinogenic potential of chemical mixtures may be more important than that of individual carcinogens in the real world [52]. It will also be critical to enhance our knowledge on chemical toxicity as according to the US EPA, it is available for less than 20% of substances produced at significant amounts, worldwide [53]. While additivity was demonstrated for mixture of low-dosed chemicals affecting similar outcomes [54], when it comes to mixtures with molecules acting differently, which better fits the real life scenario, the problem becomes more complex because chemical actions may [46; 55] or may not be independent. For example, in an *in vitro* model of mesenchymal cells, BPA, DEHP and TBT could not be deduced from single compound experiments [56]. As well synergistic activation of human PXR was observed in an *in vitro* model of hepatocytes (HepG2) by binary cocktails of pharmaceutical and environmental compounds [57]. Another limitation to the additivity concept of cocktail effect lies in the fact that a pollutant can alter the metabolism of another pollutant present in the mixture and potentially its bioavailability [58]. Moreover, some products may, by modifying the epigenome, leave an imprint on unexposed generations as recently demonstrated with TBT on RXR activation [59].

The problem posed by the cocktail effect is a virtually insurmountable challenge but it will have to be overcome for the sake of public health. Political authorities should work to reduce the exponential production of industrial chemicals. In addition, integrative approaches combining knowledge gathered in epidemiologic and biomonitoring studies, but also experimental, *in vitro* and *in silico* studies, together with computational approaches to construct predictive models, will certainly help at moving a path forward.

## Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.

## Funding

This work was supported by INSERM and University of Lyon1 to INSERM U1060

## Author Contributions
275 The manuscript was written by BLMB. DN created the Table and participated in the editing of the manuscript. HV participated in the editing of the manuscript. All authors approved the final version of the manuscript.

278

279 **References**

280 [1] WHO, World Health Organization, Obesity and Overweight, Fact sheet 311.

281 http://www.who.int/mediacentre/factsheets/fs311/en/ (2014).

282 [2] WHO, World Health Organization, Diabetes, Fact sheet 312.

283 http://www.who.int/mediacentre/factsheets/fs312/en/ (2016).

284 [3] R. Dobbs, C. Sawers, F. Thompson, J. Manyika, J. Woetzel, P. Child, S. McKenna, and A. Spatharou,

285 Overcoming obesity : an initial economic analysis. McKinsey Global Institute, Jakarta,

286 Indonesia

287 http://www.mckinsey.com/~/media/McKinsey/dotcom/Insights/Economic%20Studies

288 (2014).

289 [4] M. Tremmel, U.G. Gerdtham, P.M. Nilsson, and S. Saha, Economic Burden of Obesity: A

290 Systematic Literature Review. Int J Environ Res Public Health 14 (2017) 435.

291 [5] P. Alonso-Magdalena, I. Quesada, and A. Nadal, Endocrine disruptors in the etiology of type 2

292 diabetes mellitus. Nat Rev Endocrinol 7 (2011) 346-53.

293 [6] P.F. Baillie-Hamilton, Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern

294 Complement Med 8 (2002) 185-92.

295 [7] A.C. Gore, V.A. Chappell, S.E. Fenton, J.A. Flaws, A. Nadal, G.S. Prins, J. Toppari, and R.T. Zoeller,

296 EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting

297 Chemicals. Endocr Rev 36 (2015) E1-E150.

298 [8] B. Le Magueresse-Battistoni, E. Labaronne, H. Vidal, and D. Naville, Endocrine disrupting

299 chemicals in mixture and obesity, diabetes and related metabolic disorders. World J Biol

300 Chem 8 (2017) 108-119.

301 [9] B. Le Magueresse-Battistoni, H. Vidal, and D. Naville, Lifelong consumption of low-dosed food

302 pollutants and metabolic health. J Epidemiol Community Health 69 (2015) 512-5.

303 [10] P.M. Lind, and L. Lind, Endocrine-disrupting chemicals and risk of diabetes: an evidence-based

304 review. Diabetologia 61 (2018) 1495-1502.

305 [11] K.A. Thayer, J.J. Heindel, J.R. Bucher, and M.A. Gallo, Role of environmental chemicals in

306 diabetes and obesity: a National Toxicology Program workshop review. Environ Health

307 Perspect 120 (2012) 779-89.

308 [12] R.T. Zoeller, A. Bergman, G. Becher, P. Bjerregaard, R. Bornman, I. Brandt, T. Iguchi, S. Jobling,

309 K.A. Kidd, A. Kortenkamp, N.E. Skakkebaek, J. Toppari, and L.N. Vandenberg, A path forward

310 in the debate over health impacts of endocrine disrupting chemicals. Environ Health 13

311 (2014) 118.

312 [13] R. Barouki, P.D. Gluckman, P. Grandjean, M. Hanson, and J.J. Heindel, Developmental origins of

313 non-communicable disease: implications for research and public health. Environ Health 11

314 (2012) 42.

315 [14] P.D. Gluckman, M.A. Hanson, C. Cooper, and K.L. Thornburg, Effect of in utero and early-life

316 conditions on adult health and disease. N Engl J Med 359 (2008) 61-73.

317 [15] M.O. Milbrath, Y. Wenger, C.W. Chang, C. Emond, D. Garabrant, B.W. Gillespie, and O. Jolliet,

318 Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age,

319 body fat, smoking status, and breast-feeding. Environ Health Perspect 117 (2009) 417-25.
320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

[16] H.M. Koch, and A.M. Calafat, Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 364 (2009) 2063-78.

[17] L.N. Vandenberg, R. Hauser, M. Marcus, N. Olea, and W.V. Welshons, Human exposure to bisphenol A (BPA). Reprod Toxicol 24 (2007) 139-77.

[18] L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, Jr., D.H. Lee, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, R.T. Zoeller, and J.P. Myers, Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33 (2012) 378-455.

[19] F. Mauvais-Jarvis, D.J. Clegg, and A.L. Hevener, The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34 (2013) 309-38.

[20] L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, Jr., D.H. Lee, J.P. Myers, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, and R.T. Zoeller, Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 38 (2013) 1-15.

[21] R. Barouki, Endocrine disruptors: Revisiting concepts and dogma in toxicology. C R Biol 340 (2017) 410-413.

[22] J.J. Heindel, and B. Blumberg, Environmental Obesogens: Mechanisms and Controversies. Annu Rev Pharmacol Toxicol (2018) in press.

[23] WHO/UNEP, State of the science of endocrine disrupting chemicals - 2012. An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and WHO. Åke Bergman, Jerrold J. Heindel, Susan Jobling, Karen A. Kidd and R. Thomas Zoeller eds http://www.who.int/ceh/publications/endocrine/en/ (2013).

[24] C. Casals-Casas, and B. Desvergne, Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73 (2011) 135-62.

[25] R. Chamorro-Garcia, B.M. Shoucri, S. Willner, H. Kach, A. Janesick, and B. Blumberg, Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms, in Vitro. Environ Health Perspect 126 (2018) 057006.

[26] J.J. Heindel, B. Blumberg, M. Cave, R. Machtinger, A. Mantovani, M.A. Mendez, A. Nadal, P. Palanza, G. Panzica, R. Sargis, L.N. Vandenberg, and F. Vom Saal, Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 68 (2017) 3-33.

[27] A. Nadal, I. Quesada, E. Tuduri, R. Nogueiras, and P. Alonso-Magdalena, Endocrine-disrupting chemicals and the regulation of energy balance. Nat Rev Endocrinol 13 (2017) 536-546.

[28] E. Silva, N. Rajapakse, and A. Kortenkamp, Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol 36 (2002) 1751-6.

[29] U. Hass, M. Scholze, S. Christiansen, M. Dalgaard, A.M. Vinggaard, M. Axelstad, S.B. Metzdorff, and A. Kortenkamp, Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environ Health Perspect 115 Suppl 1 (2007) 122-8.

[30] F. Orton, S. Ermler, S. Kugathas, E. Rosivatz, M. Scholze, and A. Kortenkamp, Mixture effects at very low doses with combinations of anti-androgenic pesticides, antioxidants, industrial pollutant and chemicals used in personal care products. Toxicol Appl Pharmacol 278 (2014) 201-8.

[31] M. Van den Berg, L. Birnbaum, A.T. Bosveld, B. Brunstrom, P. Cook, M. Feeley, J.P. Giesy, A. Hanberg, R. Hasegawa, S.W. Kennedy, T. Kubiak, J.C. Larsen, F.X. van Leeuwen, A.K. Liem, C. Nolt, R.E. Peterson, L. Poellinger, S. Safe, D. Schrenk, D. Tillitt, M. Tysklind, M. Younes, F. Waern, and T. Zacharewski, Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106 (1998) 775-92.

[32] J. Ruzzin, R. Petersen, E. Meugnier, L. Madsen, E.J. Lock, H. Lillefosse, T. Ma, S. Pesenti, S.B. Sonne, T.T. Marstrand, M.K. Malde, Z.Y. Du, C. Chavez, L. Fajas, A.K. Lundebye, C.L. Brand, H. Vidal, K. Kristiansen, and L. Froyland, Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 118 (2010) 465-71.
372

373

374

375

[33] M.M. Ibrahim, E. Fjaere, E.J. Lock, D. Naville, H. Amlund, E. Meugnier, B. Le Magueresse Battistoni, L. Froyland, L. Madsen, N. Jessen, S. Lund, H. Vidal, and J. Ruzzin, Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice. PLoS One 6 (2011) e25170.

376

377

378

379

[34] D. Naville, C. Pinteur, N. Vega, Y. Menade, M. Vigier, A. Le Bourdais, E. Labaronne, C. Debard, C. Luquain-Costaz, M. Begeot, H. Vidal, and B. Le Magueresse-Battistoni, Low-dose food contaminants trigger sex-specific, hepatic metabolic changes in the progeny of obese mice. FASEB J 27 (2013) 3860-70.

380

381

382

383

[35] E. Labaronne, C. Pinteur, N. Vega, S. Pesenti, B. Julien, E. Meugnier-Fouilloux, H. Vidal, D. Naville, and B. Le Magueresse-Battistoni, Low-dose pollutant mixture triggers metabolic disturbances in female mice leading to common and specific features as compared to a high-fat diet. J Nutr Biochem 45 (2017) 83-93.

384

385

386

[36] B. Le Magueresse-Battistoni, L. Multigner, C. Beausoleil, and C. Rousselle, Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption. Mol Cell Endocrinol (2018).

387

388

389

390

391

392

[37] C. Beausoleil, C. Emond, J.P. Cravedi, J.P. Antignac, M. Applanat, B.M.R. Appenzeller, R. Beaudouin, L.P. Belzunces, M.C. Canivenc-Lavier, N. Chevalier, C. Chevrier, E. Elefant, F. Eustache, R. Habert, M. Kolf-Clauw, B. Le Magueresse-Battistoni, S. Mhaouty-Kodja, C. Minier, L. Multigner, H. Schroeder, P. Thonneau, C. Viguie, F. Pouzaud, J.N. Ormsby, C. Rousselle, L. Verines-Jouin, E. Pasquier, and C. Michel, Regulatory identification of BPA as an endocrine disruptor: Context and methodology. Mol Cell Endocrinol (2018).

393

394

[38] M.S. Mimoto, A. Nadal, and R.M. Sargis, Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals. Curr Environ Health Rep 4 (2017) 208-222.

395

396

397

398

[39] A. Nadal, E. Fuentes, C. Ripoll, S. Villar-Pazos, M. Castellano-Munoz, S. Soriano, J. Martinez-Pinna, I. Quesada, and P. Alonso-Magdalena, Extranuclear-initiated estrogenic actions of endocrine disrupting chemicals: Is there toxicology beyond paracelsus? J Steroid Biochem Mol Biol 176 (2018) 16-22.

399

400

401

[40] B. Le Magueresse-Battistoni, H. Vidal, and D. Naville, Sex-specific metabolic alterations induced by environmental pollutants. Current Opinion in Toxicology 8 (2018) 1-7 http://www.hal.inserm.fr/inserm-01743795.

402

403

404

[41] D. Naville, E. Labaronne, N. Vega, C. Pinteur, E. Canet-Soulas, H. Vidal, and B. Le Magueresse-Battistoni, Metabolic outcome of female mice exposed to a mixture of low-dose pollutants in a diet-induced obesity model. PLoS ONE 10 (2015) e0124015.

405

406

[42] F. Mauvais-Jarvis, Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ 6 (2015) 14.

407

408

[43] Y. Lin, L. Min, Q. Huang, Y. Chen, C. Fang, X. Sun, and S. Dong, The combined effects of DEHP and PCBs on phospholipase in the livers of mice. Environ Toxicol 30 (2015) 197-204.

409

410

411

412

[44] C. Mulligan, S. Kondakala, E.J. Yang, J.V. Stokes, J.A. Stewart, B.L. Kaplan, and G.E. Howell, 3rd, Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls Promotes hepatic steatosis in male Ob/Ob mice. Environ Toxicol 32 (2017) 1399-1411.

413

414

415

416

417

418

[45] C. Lukowicz, C. Ellero-Simatos, M. Régnier, A. Polizzi, F. Lasserre, A. Montagner, Y. Lippi, E.L. Jamin, J.-F. Martin, C. Naylies, C. Canlet, L. Debrauwer, J. Bertrand-Michel, T. AlSaati, V. Théodorou, N. Loiseau, L. Mselli-Lakhal, H. Guillou, and L. Gamet-Payrastre, Metabolic Effects of aChronic Dietary Exposure to a Low-Dose Pesticide Cocktail in Mice: Sexual Dimorphism and Role of the Constitutive Androstane Receptor. Environmental Health Perspectives in press (2018).

419

420

421

[46] T. Svingen, L. Ramhoj, K. Mandrup, S. Christiansen, M. Axelstad, A.M. Vinggaard, and U. Hass, Effects on metabolic parameters in young rats born with low birth weight after exposure to a mixture of pesticides. Sci Rep 8 (2018) 305.
422 [47] O. Carnevali, V. Notarstefano, I. Olivotto, M. Graziano, P. Gallo, I. Di Marco Pisciottano, L.
423 Vaccari, A. Mandich, E. Giorgini, and F. Maradonna, Dietary administration of EDC mixtures:
424 A focus on fish lipid metabolism. Aquat Toxicol 185 (2017) 95-104.

425 [48] F. Mauvais-Jarvis, A.P. Arnold, and K. Reue, A Guide for the Design of Pre-clinical Studies on Sex
426 Differences in Metabolism. Cell Metab 25 (2017) 1216-1230.

427 [49] C. Duval, F. Teixeira-Clerc, A.F. Leblanc, S. Touch, C. Emond, M. Guerre-Millo, S. Lotersztajn, R.
428 Barouki, M. Aggerbeck, and X. Coumoul, Chronic Exposure to Low Doses of Dioxin Promotes
429 Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model. Environ
430 Health Perspect 125 (2017) 428-436.

431 [50] N. Buron, M. Porceddu, C. Roussel, K. Begriche, V. Trak-Smayra, T. Gicquel, B. Fromenty, and A.
432 Borgne-Sanchez, Chronic and low exposure to a pharmaceutical cocktail induces
433 mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean
434 and obese mice. Environ Toxicol 32 (2017) 1375-1389.

435 [51] K. Oshida, D.J. Waxman, and J.C. Corton, Chemical and Hormonal Effects on STAT5b-Dependent
436 Sexual Dimorphism of the Liver Transcriptome. PLoS One 11 (2016) e0150284.

437 [52] D.H. Lee, D.R. Jacobs, Jr., H.Y. Park, and D.O. Carpenter, A role of low dose chemical mixtures in
438 adipose tissue in carcinogenesis. Environ Int 108 (2017) 170-175.

439 [53] D.A. Sarigiannis, and U. Hansen, Considering the cumulative risk of mixtures of chemicals - a
440 challenge for policy makers. Environ Health 11 Suppl 1 (2012) S18.

441 [54] A. Kortenkamp, Low dose mixture effects of endocrine disrupters and their implications for
442 regulatory thresholds in chemical risk assessment. Curr Opin Pharmacol 19 (2014) 105-11.

443 [55] A. Kortenkamp, Ten years of mixing cocktails: a review of combination effects of endocrine-
444 disrupting chemicals. Environ Health Perspect 115 Suppl 1 (2007) 98-105.

445 [56] R. Biemann, B. Fischer, and A. Navarrete Santos, Adipogenic effects of a combination of the
446 endocrine-disrupting compounds bisphenol A, diethylhexylphthalate, and tributyltin. Obes
447 Facts 7 (2014) 48-56.

448 [57] V. Delfosse, B. Dendele, T. Huet, M. Grimaldi, A. Boulaitouf, S. Gerbal-Chaloin, B. Beucher, D.
449 Roecklin, C. Muller, R. Rahmani, V. Cavailles, M. Daujat-Chavanieu, V. Vivat, J.M. Pascussi, P.
450 Balaguer, and W. Bourguet, Synergistic activation of human pregnane X receptor by binary
451 cocktails of pharmaceutical and environmental compounds. Nat Commun 6 (2015) 8089.

452 [58] T. Pollock, R.E. Weaver, R. Ghasemi, and D. deCatanzaro, A mixture of five endocrine-disrupting
453 chemicals modulates concentrations of bisphenol A and estradiol in mice. Chemosphere 193
454 (2018) 321-328.

455 [59] B.M. Shoucri, V.T. Hung, R. Chamorro-Garcia, T. Shioda, and B. Blumberg, Retinoid X receptor
456 activation during adipogenesis of female mesenchymal stem cells programs a dysfunctional
457 adipocyte. Endocrinology 159 (2018) 2863-2883.

458 [60] A.O. Docea, E. Gofita, M. Goumenou, D. Calina, O. Rogoveanu, M. Varut, C. Olaru, E. Kerasioti, P.
459 Fountoucidou, I. Taitzoglou, O. Zlatian, V.N. Rakitskii, A.F. Hernandez, D. Kouretas, and A.
460 Tsatsakis, Six months exposure to a real life mixture of 13 chemicals' below individual
461 NOAELs induced non monotonic sex-dependent biochemical and redox status changes in
462 rats. Food Chem Toxicol 115 (2018) 470-481.

463

464

465
<table><caption>466 **Table 1:** Metabolic effects of pollutants in mixture and sex-dimorphism</caption><thead><tr><td>Mixture of pollutants</td><td>Composition</td><td>Animal Model</td><td>Metabolic effects of the mixture</td><td>References</td></tr></thead><tbody><tr><td>Natural mixture: crude or refined salmon oil in high-fat (HF) diet</td><td>mixture of Persistent Organic Pollutants (POPs): organochloride pesticide, Dichlorodiphenyltrichloroéthane (DDTs), dioxins, Polychlorobiphenyls (PCBs)</td><td>Adult male Sprague-Dawley rat (28 days of exposure)</td><td>HF+ crude oil vs HF: insulin resistance, abdominal obesity, liver steatosis, down-regulation of genes involved in lipid homeostasis (Insig-1 and Lipin 1) in liver</td><td>Ruzzin et al, 2010 [32]</td></tr><tr><td>Very high fat diet (VHF) or Western diet (WD) containing farmed salmon fillet (VHF/S and WD/S)</td><td>mixture of Persistent Organic Pollutants (POPs): organochloride pesticides, dioxins, furans and Polychlorobiphenyls (PCBs)</td><td>8-week old male C57BL/6J mice (8 weeks exposure for VHF; 6 weeks for WD)</td><td>VHF/S vs VHF: aggravation of insulin resistance, visceral obesity and glucose intolerance, adipose tissue inflammation. Increased blood glucose and plasma insulin. WD/S vs WD: enhanced body weight, overgrowth of adipose tissue, increased glucose intolerance and insulin resistance with increased plasma insulin</td><td>Ibrahim et al, 2011 [33]</td></tr><tr><td>Combination of four Endocrine Disrupting Chemicals (EDCs) in high fat-high sucrose (HFHS) diet</td><td>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), Polychlorobiphenyls (PCB) 153, Bisphenol A (BPA), di (2-ethylhexyl) phthalate (DEHP) each at reference doses (Tolerable Daily Intake, TDI for Human)</td><td>Male and female C57BL/6J mouse (exposure from pre-conception, gestation to 12 weeks of life)</td><td>Sex-dependent metabolic disorders in the absence of weight gain. In males, increased hepatic expression of genes encoding proteins related to cholesterol biosynthesis associated with a decrease in hepatic total cholesterol levels. In females, marked deterioration of glucose tolerance associated with decreased expression of gene encoding ERα as well as estrogen target genes and increased expression of gene encoding the estrogen sulfotransferase SULT1E1.</td><td>Naville et al, 2013 [34]</td></tr></tbody></table>
<table><tr><td>Combination of Endocrine Disrupting Chemicals (EDCs) administered intragastrically to the exposed group.</td><td>Combination of di (2-ethylhexyl) phthalate, DEHP (15mg/kg bw) with a mixture of Polychlorobiphenyls, PCBs (Aroclor 1254 at 7.5mg/Kg bw/day)</td><td>female and male mice (12 days of exposure)</td><td>Increased liver weight but no difference in body weight; in liver, increased expression of gene encoding Peroxisome Proliferator-Activated Receptor (PPAR)γ (males and females), decreased expression of genes encoding Estrogen Receptor (ER)α and phospholipase A (PLA) only in males</td><td>Lin et al, 2015 [43]</td></tr><tr><td>Different combinations of 3 pollutants (2 by 2 or all 3)</td><td>Nonylphenol (NP), tert-octylphenol (t-OP), Bisphenol A (BPA) (5mg/kg bw/day of each)</td><td>Juvenile seabream (21 days)</td><td>Hepatic steatosis, modulation of the expression of genes involved in lipid metabolism (ppars, lpl, fasn, hsl) mostly using NP+t-OP or BPA+NP. Effects milder than those obtained with one chemical (hypothesis of possible interactions among compounds).</td><td>Carnevali et al, 2017 [47]</td></tr><tr><td>Combination of four Endocrine Disrupting Chemicals (EDCs) in low fat diet</td><td>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), Polychlorobiphenyls (PCB) 153, Bisphenol A (BPA), di (2-ethylhexyl) phthalate (DEHP) each at reference doses (Tolerable Daily Intake, TDI for Human)</td><td>female C57Bl6/J mouse (exposure from pre-conception, gestation to 12 weeks of life)</td><td>Alteration of lipid homeostasis (increase of hepatic triglycerides) with no difference in body weight or glucose tolerance. Transcriptome analysis in liver highlights dysregulation of genes involved in fatty acid/lipid and circadian clock metabolic pathway. Most of these effects were observed in females and not in males.</td><td>Labaronne et al, 2017 [35]</td></tr></table>
<table><tr><td>Mixture of five<br>prevalent<br>organochlorine<br>pesticides or their<br>metabolites and five<br>Polychlorobiphenyls<br>(PCBs) present in<br>contaminated<br>salmon [32]</td><td>Dichlorodiphenyldichloroethylene(p,p'DDE);<br>Dichlorodiphenyldichloroéthane<br>(p,p'DDD); hexachlorobenzene,<br>dieldrin, trans-nonachlor, PCB-153,<br>PCB-138, PCB-118, PCB-77,<br>PCB-126 (oral gavage twice<br>weekly during 7 weeks)</td><td>5 week-old<br>male wild<br>type<br>C57BL/6J<br>and male<br>ob/ob mice</td><td>Alteration of systemic<br>lipid metabolism in<br>ob/ob mice: increased<br>hepatic triglycerides<br>(TG) with decrease of<br>serum TG levels (no<br>difference either in<br>plasma glucose or<br>insulin levels or in<br>inflammation in liver or<br>adipose tissue).<br>Induction of the<br>expression of Cyp3a11<br>in WT mice not in ob/ob<br>mice</td><td>Mulligan et<br>al, 2017<br>[44]</td></tr><tr><td>Mixture of 13<br>chemicals</td><td>Carbaryl, dimethoate, glyphosate,<br>methomyl, methyl parathion,<br>triadimefon, aspartame, sodium<br>benzoate,<br>Ethylenediaminetetraacetic acid<br>(EDTA), ethylparaben,<br>butylparaben, BPA, acacia gum (6-<br>month exposure in drinking water<br>at three different doses: low,<br>medium and high).</td><td>8-week old<br>Female and<br>Male<br>Sprague-<br>Dawley rats</td><td>Increased body weight<br>and alteration of<br>hepatotoxic parameters<br>(increased level of total<br>bilirubin, alanine<br>aminotransferase and<br>alkaline phosphatase)<br>even at low dose and<br>only in males. Increased<br>catalase activity with the<br>low doses both in males<br>and females. Also<br>evidence for sex<br>differences in some<br>markers of the redox<br>status (catalase levels,<br>protein carbonyls).</td><td>Docea et al,<br>2018<br>[60]</td></tr><tr><td>Mixture of 4<br>fungicides and 2<br>insecticides in<br>standard diet</td><td>Ziram; Chlorpyrifos; Thiacloprid;<br>Boscalid; Thiofanate; Captan (52<br>weeks of exposure; at Tolerable<br>Daily Intake, TDI for Humans)</td><td>16-week-old<br>female and<br>male<br>C57BL/6J<br>(WT) and<br>Constitutive<br>Androstane<br>Receptor<br>(CAR)-<br>invalidated<br>mice</td><td>In Wild Type (WT)<br>males: increased body<br>weight (not seen in male<br>CAR-/-) and adiposity,<br>hepatic steatosis, fasting<br>hyperglycemia and<br>strong glucose<br>intolerance.<br>In WT females: fasting<br>hyperglycemia and slight<br>glucose intolerance.<br>Pesticide-exposed CAR-/-<br>females exhibited<br>pesticide toxicity with<br>increased body weight<br>and mortality rate.<br>Sexually dimorphic<br>alterations of various<br>metabolic pathways</td><td>Lukowicz et<br>al, 2018<br>[45]</td></tr></table>
<table><tr><td>Pesticide mixture containing six chemicals at 3 different doses (noted 5%-16%-37.5%)</td><td>Cyromazine, MCPB (4-(4-chloro-2-methylphenoxy) butanoic acid), Pirimicarb, Quinoclamine, Thiram, Ziram (daily oral gavage of pregnant rats from gestation day 7 to pup day 16)</td><td>Wistar rats - Male and Female offspring studied until 15 weeks of life</td><td>Decreased body weight at birth for both sexes with the highest dose. No difference in body weight after 15 weeks. Differences observed between males and females for several regulatory factors (such as leptin).</td><td>Svingen et al, 2018 [46]</td></tr></table>

467

468